A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

Metastases and resistance to chemotherapy are the main causes of treatment failure and mortality in cancer patients. Epithelial-mesenchymal transition (EMT), a process by which cancer cells detach from their neighboring cells and acquire invasive properties, plays a key role in the formation of metastases and the development of resistance to anti-cancer treatments. To date, there is no therapy targeting EMT in cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *